Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Perimeter Medical Imaging AI ( (TSE:PINK) ) has issued an announcement.
Perimeter Medical Imaging AI said it will release its fourth quarter and full-year 2025 financial and operating results after markets close on March 31, 2026, followed by a webcast and conference call with management to discuss the numbers and provide a corporate update. The event underscores the company’s transition as a commercial-stage player in cancer surgery imaging, with investors likely focused on adoption of its newly approved Claire OCT System and corresponding revenue trajectory.
The company also disclosed that major investor Social Capital has agreed to cancel 14,466,667 common share purchase warrants at no consideration, significantly reducing potential future share dilution. Following the cancellation, Social Capital’s ownership remains at 22.2% of Perimeter’s outstanding common shares on a non-diluted basis, but its partially diluted stake falls from 30% to 22.3%, a move that simplifies Perimeter’s capital structure and may be viewed positively by existing shareholders.
The most recent analyst rating on (TSE:PINK) stock is a Buy with a C$3.00 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.
Spark’s Take on PINK Stock
According to Spark, TipRanks’ AI Analyst, PINK is a Neutral.
The score is held down primarily by weak financial quality (persistent losses and negative operating/free cash flow) despite solid gross margins and revenue growth, and by bearish technicals with the stock trading below key moving averages. Valuation adds limited support because the negative P/E reflects ongoing losses and no dividend yield is available.
To see Spark’s full report on PINK stock, click here.
More about Perimeter Medical Imaging AI
Perimeter Medical Imaging AI, Inc. is a commercial-stage medical technology company based in Toronto and Dallas that focuses on transforming cancer surgery with ultra-high-resolution, real-time imaging tools. Its next-generation AI-enabled device, the Claire OCT System, recently approved by the FDA, is designed as an adjunctive tool to help surgeons evaluate breast cancer lumpectomy margins alongside standard methods.
Average Trading Volume: 214,548
Technical Sentiment Signal: Hold
Current Market Cap: C$58.64M
For a thorough assessment of PINK stock, go to TipRanks’ Stock Analysis page.